Stock Events

Stock Events

Vivesto AB 

€0
2
+€0+0% Tuesday 06:10

Statistics

Day High
0
Day Low
0
52W High
0.02
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
1.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

21NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Q3 2024
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-11.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OMAX.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc is a major player in the medical technology, services, and solutions sector, directly competing with Vivesto AB in the medical devices market.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation specializes in the development of medical devices that are used in various interventional medical specialties, competing with Vivesto AB's offerings.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a leader in the medical technology industry and competes with Vivesto AB in the orthopedics and surgical sectors.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories operates globally in more than 160 countries, offering a broad range of healthcare products that compete with Vivesto AB's medical devices.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a comprehensive healthcare firm that manufactures medical devices, pharmaceuticals, and consumer health products, competing across multiple fronts with Vivesto AB.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare and competes with Vivesto AB in the orthopedic device sector.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, directly competing with Vivesto AB's technological innovations in surgery.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation is focused on advanced medical equipment for structural heart disease and critical care monitoring, competing with Vivesto AB's similar medical device solutions.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and renal care products, competing with Vivesto AB in the medical supplies sector.

About

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Show more...
CEO
Mr. Erik Kinnman Assoc. Prof., M.B.A., M.D., Ph.D.
Employees
4
Country
DE
ISIN
SE0000722365
WKN
000509722

Listings

LSE
GB
0N4A.LSE
ST
SE
VIVE.ST
OTC Link
US
OASMY
F
DE
OMAX.F

0 Comments

Share your thoughts

FAQ

What is Vivesto AB stock price today?▼
The current price of OMAX.F is €0 EUR — it has increased by +0% in the past 24 hours. Watch Vivesto AB stock price performance more closely on the chart.
What is Vivesto AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vivesto AB stocks are traded under the ticker OMAX.F.
Is Vivesto AB stock price growing?▼
OMAX.F stock has fallen by -16.67% compared to the previous week, the month change is a -25.93% fall, over the last year Vivesto AB has showed a -90.95% decrease.
What is Vivesto AB market cap?▼
Today Vivesto AB has the market capitalization of 1.08M
What is Vivesto AB revenue for the last year?▼
Vivesto AB revenue for the last year amounts to 0 EUR.
What is Vivesto AB net income for the last year?▼
OMAX.F net income for the last year is -11.91M EUR.
How many employees does Vivesto AB have?▼
As of April 01, 2026, the company has 4 employees.
When did Vivesto AB complete a stock split?▼
Vivesto AB has not had any recent stock splits.
Where is Vivesto AB headquartered?▼
Vivesto AB is headquartered in Solna, DE.